Pfizer to buy Allergan for about $160B

Pfizer announced Monday it will buy Allergan for $363.63 a share, or about $160 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.